PROTAC (Proteolysis Targeting Chimera) technology represents a novel approach to drug development, particularly in the realm of cancer therapeutics. This innovative strategy enables targeted protein ...

While the human genome encodes more than 600 different E3 ligases, current PROTACs use only a handful of them, drastically limiting their full potential. Furthermore, many PROTAC development campaigns ...

Since 1973, Streamlight, Inc. has designed, manufactured, and marketed high-performance flashlight products, and today offers a broad array of lights, lanterns, weapon light/laser sighting devices ...